comparemela.com
Home
Live Updates
Keynote 775 - Breaking News
Pages:
Latest Breaking News On - Keynote 775 - Page 1 : comparemela.com
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
The expert panel reviews the KEYNOTE-775 trial, which focused on lenvatinib and pembrolizumab in advanced endometrial cancer.
Matthewa powell
Bhavana pothuri
Ursulaa matulonis
Shannonn westin
New england journal
Endometrial cancer
Keynote 775
Mismatch repair
Checkpoint inhibition
Nrg gy025
Nrg gy020
Ruby trial
Nrg gy018
Gog 3053
Dr Barber on the Significance of the KEYNOTE-775 Trial for the Second-line Treatment of Endometrial Cancer
Emma L. Barber, MD, discusses how key data from the phase 3 KEYNOTE-775 study improved the identification of patient populations within endometrial cancer that benefit from second-line immunotherapy.
Northwestern university feinberg school of medicine
Division of gynecologic oncology
Gynecologic oncology
Northwestern university feinberg school
Robotic surgery
Northwestern medicine
Gynecologic oncology
Onclive tv
Roberth lurie comprehensive cancer center of northwestern university medicine
Endometrial cancer
Keynote 775
Immune checkpoint inhibitor
Second line
Mismatch repair deficiency
vimarsana © 2020. All Rights Reserved.